The use of 25% human serum albumin: Outcome and efficacy in raising serum albumin and systemic blood pressure in critically ill dogs and cats

Journal of Veterinary Emergency and Critical Care

Volumn 15, Issue 2, 2005, Pages 110-118

  Mathews, Karol A ^a   Barry, Maureen ^a  

^a UNIVERSITY OF GUELPH   (Canada)

Author keywords

Colloid; Hypoalbuminemia; Hypotension; Small animal

Indexed keywords

ANIMALIA; CANIS FAMILIARIS;

EID: 27644577671     PISSN: 14793261     EISSN: 14764431     Source Type: Journal    
DOI: 10.1111/j.1476-4431.2005.00141.x     Document Type: Article

References (48)

1. Wheeler AP, Bernard GR. Treating patients with sepsis. N Engl J Med 1999; 340:207-214.
2. Guyton AC, Lindsey AW. Effect of elevated left atrial pressure and decreased plasma protein concentration on the development of pulmonary edema. Circ Res 1959; 7:649-657.
3. Martin GS, Bernard GR. Airway and lung dysfunction in sepsis. Intensive Care Med 2001; Suppl.:S2763-S2779.
4. Ferguson ND, Meade MO, Hallett DC, et al. High values of the pulmonary artery wedge pressure in patients with acute lung injury and acute respiratory distress syndrome. Intensive Care Med 2002; 28:1073-1077.
5. Sakka SG, Klein M, Reinhart K, et al. Prognostic value of extra-vascular lung water in critically ill patients. Chest 2002; 122: 2080-2086.
6. Smiley LE. The use of hetastarch for plasma expansion. Probl Vet Med 1992; 4(4):652-667.
7. Rudloff E, Kirby R. Hypovolemic shock and resuscitation. Vet Clin North Am Small Anim Pract 1994; 24(6):1015-1039.
8. Kirby R, Rudloff E. The critical need for colloids: maintaining fluid balance. Comp Cont Ed Pract Vet 1997; 19:705-718.
9. Rudloff E, Kirby R. The critical need for colloids: selecting the right colloid. Comp Cont Ed Pract Vet 1997; 19:811-826.
10. Rudloff E, Kirby R. The critical need for colloids: administering colloids effectively. Comp Cont Ed Pract Vet 1998; 20:27-43.
11. Rudloff E, Kirby R. Fluid therapy. Crystalloids and colloids. Vet Clin North Am Small Anim Prac 1998; 28:297-328.
12. Weeren FR, Muir WW. Clinical aspects of septic shock and comprehensive approaches to treatment in dogs. J Am Vet Med Assoc 1992; 200(12):1859-1869.
13. Holbeck S, Grande P. Effects on capillary fluid permeability and fluid exchange of albumin, dextran, gelatin and hydroxyetheyl starch in cat skeletal muscle. Crit Care Med 2000; 28(4):1089-1095.
14. Mishler JM. Synthetic plasma volume expanders: their pharmacology, safety and clinical efficacy. Clin Haematol 1984; 13:75-92.
15. Nicholson JP, Wolmarans MR, Park GR. The role of albumin in critical illness. Br J Anaesthesia 2000; 85:599-610.
16. Hughes D. Fluid therapy with macromolecular plasma volume expanders, In: Di Bartola SP Di Bartola's Fluid Therapy in Small Animal Practice, 2nd edn, Philadelphia: WB Saunders Co; 2000, Chapter 23, pp. 483-495.
17. Mazzaferro EM, Rudloff E, Kirby R. The role of albumin replacement in the critically ill veterinary patient. J Vet Emerg Crit Care 2002; 12(2):113-124.
18. Watts JA, Maiorano PC. Trace amounts of albumin protect against ischemia and reperfusion injuiry in isolated rat hearts. J Mol Cell Cardiol 199; 31:1653-1662.
19. Mathews KM. Various types of parenteral fluids and their indications. Vet Clin North Am Sm Anim Pract 1998; 28(3):498-504.
20. Abrams-Ogg A. Practical blood transfusion, In: Day MJ, Mackin A, Littlewood JD. eds. BSAVA Manual of Canine and Feline Hematology and Transfusion Medicine. Gloucester, UK: British Small Animal Veterinary Association; 2000, pp. 263-303.
21. Cotter S. Clinical transfusion medicine. Adv Vet Sci Comp Med 1991; 36:187-223.
22. Kristensen AT. Administration of blood products to animals, In: Bistner SI, Ford RB. eds. Kirk and Bistner's Handbook of Veterinary Procedures and Emergency Treatment. Philadelphia: WB Saunders Co; 1995, pp. 561-573.
23. Dubois M-J, Vincent J-L. Use of albumin in the intensive care unit. Curr Opinion Crit Care 2002; 8:299-301.
24. Martin GS, Mangialardi RJ, Wheeler AP, et al. Albumin and furosemide therapy in hypoproteinemic patients with acute lung injury. Crit Care Med 2002; 30:2175-2182.
25. Harvey H. Complication of small intestinal biopsy in hypoalbuminemic dogs. Vet Surg 1990; 19:289.
26. Powers KA, Kapus A, Khadaroo RG, et al. Twenty-five percent albumin prevents lung injury following shock/ resuscitation. Crit Care Med 2003; 31:2355-2363.
27. Emmerson TE Jr. Unique features of albumin: a brief review. Crit Care Med 1989; 17:690-694.
28. King TP. On the sulfhydryl group of human plasma albumin. J Biol Chem 1961; 236:PC5.
29. Peters T Jr. Serum albumin. Adv Protein Chem 1985; 37:161-245.
30. Quinlan GJ, Mumby S, Martin GS, et al. Albumin influences total plasma antioxidant capacity favourably in patients with acute lung injury. Crit Care Med 2004; 32(3):755-759.
31. Bourdon E, Blache D. The importance of proteins in defense against oxidation. Antioxid Redox Signal 2001; 3:293-311.
32. Rhee P, Wang D, Ruff P. Human neutrophil activation and increased adhesion by various resuscitation fluids. Crit Care Med 2000; 28:74-78.
33. Deb S, Sun I, Martin B. Lactated Ringer's solution and hetastarch but not plasma resuscitation after rat hemorrhagic shock is associated with immediate lung apoptosis by the up-regulation of the Bax protein. J Trauma 2000; 49:47-53.
34. Zoellner H, Hou JY, Lovery M. Inhibition of microvascular endothelial apoptosis in tissue explants by serum albumin. Microvasc Res 1999; 57:162-173.
35. Logan JC, Callan MB, Drew K, et al. Clinical indications for use of fresh frozen plasma in dogs: 74 dogs (October through December 1999). J Am Vet Med Assoc 2001; 218:1449-1455.
36. Scatchard G, Batchelder AC, Brown A. Chemical, clinical and immunological studies on the products of human plasma frationation. VI. The osmotic pressure of plasma and of serum albumin. J Clin Invest 1944; 23:458-464.
37. Cochrane Injuries Group Albumin Reviewers. Human albumin administration in critically ill patients: systematic review of randomized controlled trials. Br Med J 1998; 317:235-240.
38. von Hoegen I, Waller C. Safety of human albumin based on spontaeneously reported serious adverse events. Crit Care Med 2001; 29:994-996.
39. Choi PT, Yip G, Quinonez LG, et al. Crystalloids vs colloids in fluid resuscitation: a systematic review. Crit Care Med 1999; 27:200-221.
40. Allison SP, Lobo DN. Debate: albumin administration should not be avoided. Crit Care (London) 2000; 4(3):147-150.
41. Wilkes MM, Navickis RJ. Patient survival after human albumin administration. Ann Intern Med 2001; 135:149-164.
42. Boldt J. The good, the bad and the ugly: should we completely banish human albumin from our intensive care units? Anesth Analg 2000; 91:887-895.
43. Vincent J-L, Dubois M-J, Navickis RJ, et al. Hypoalbuminemia in acute illness: is there a rationale for intevention. A meta-analysis of cohort studies and controlled trials. Ann Surg 2003; 237(3): 319-334.
44. Vincent JL. Fluids for resuscitation. Br J Anaesthesia 1991; 67: 185-193.
45. Finfer S, Bellomo R, Boyce N, et al. A comparison of albumin and saline for fluid resuscitation in the intensive care unit. N Engl J Med 2004; 350:2247-2256.
46. Sort P, Navasa M, Arroyo V, et al. Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis. N Engl J Med 1999; 341:403-409.
47. Griffel MI, Kaufman BS. Pharmacology of colloids and crystalloids. Crit Care Clin 1992; 8(2):235-253.
48. Vincent JL. Fuid management: the pharmacoeconomic dimension. Crit Care 2000; 4(2):S33-S35.